FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297242573> ?p ?o ?g. }

• W4297242573 endingPage "931" @default.
• W4297242573 startingPage "921" @default.
• W4297242573 abstract "The outcomes and best treatment strategies for germline BRCA1/2 mutation (gBRCAm) carriers with metastatic breast cancer (MBC) remain uncertain. We compared the overall survival and the first line progression free survival (PFS1) of patients with a gBRCAm identified at initiation of first-line treatment with those of BRCA wild-type (WT) and not-tested (NT) individuals in the ESME real-world database of MBC patients between 2008 and 2016 (NCT03275311). Among the 20 624 eligible patients, 325 had a gBRCAm, 1138 were WT and 19 161 NT. Compared with WT, gBRCAm carriers were younger, and had more aggressive diseases. At a median follow-up of 50.5 months, median OS was 30.6 (95%CI: 21.9-34.3), 35.8 (95%CI: 32.2-37.8) and 39.3 months (95% CI: 38.3-40.3) in the gBRCAm, WT and NT subgroups, respectively. Median PFS1 was 7.9 (95%CI: 6.6-9.3), 7.8 (95%CI: 7.3-8.5) and 9.7 months (95%CI, 9.5-10.0). In the multivariable analysis conducted in the whole cohort, gBRCAm status had however no independent prognostic impact on OS and PFS1. Though, in the triple-negative subgroup, gBRCAm patients had better OS and PFS1 (HR vs WT = 0.76; 95%CI: 0.60-0.97; P = .027 and 0.69; 95% CI: 0.55-0.86; P = .001, respectively). In contrast, in patients with HR+/HER2 negative cancers, PFS1 appeared significantly and OS non significantly lower for gBRCAm carriers (PFS1: HR vs WT = 1.23; 95%CI: 1.03-1.46; P = .024; OS:HR = 1.22, 95% CI: 0.97-1.52, P = .089). In conclusion, gBRCA1/2 status appears to have divergent survival effects in MBC according to IHC subtype." @default.
• W4297242573 created "2022-09-28" @default.
• W4297242573 creator A5001731251 @default.
• W4297242573 creator A5006619822 @default.
• W4297242573 creator A5006642161 @default.
• W4297242573 creator A5015719789 @default.
• W4297242573 creator A5023263355 @default.
• W4297242573 creator A5025060489 @default.
• W4297242573 creator A5032686530 @default.
• W4297242573 creator A5034753221 @default.
• W4297242573 creator A5035439475 @default.
• W4297242573 creator A5041410352 @default.
• W4297242573 creator A5041911544 @default.
• W4297242573 creator A5043665560 @default.
• W4297242573 creator A5049369439 @default.
• W4297242573 creator A5053668514 @default.
• W4297242573 creator A5056961294 @default.
• W4297242573 creator A5067379430 @default.
• W4297242573 creator A5068016669 @default.
• W4297242573 creator A5079006574 @default.
• W4297242573 creator A5083142899 @default.
• W4297242573 creator A5083715943 @default.
• W4297242573 creator A5084631227 @default.
• W4297242573 creator A5090608495 @default.
• W4297242573 date "2022-10-08" @default.
• W4297242573 modified "2023-10-12" @default.
• W4297242573 title "Survival outcomes of metastatic breast cancer patients by germline <i>BRCA1/2</i> status in a large multicenter real‐world database" @default.
• W4297242573 cites W1995777454 @default.
• W4297242573 cites W2017289276 @default.
• W4297242573 cites W2029151927 @default.
• W4297242573 cites W2046056066 @default.
• W4297242573 cites W2114484488 @default.
• W4297242573 cites W2138733479 @default.
• W4297242573 cites W2141855743 @default.
• W4297242573 cites W2285805243 @default.
• W4297242573 cites W2560635244 @default.
• W4297242573 cites W2594380685 @default.
• W4297242573 cites W2621271973 @default.
• W4297242573 cites W2734897937 @default.
• W4297242573 cites W2782723462 @default.
• W4297242573 cites W2796557635 @default.
• W4297242573 cites W2801956643 @default.
• W4297242573 cites W2805956109 @default.
• W4297242573 cites W2881463645 @default.
• W4297242573 cites W2885738414 @default.
• W4297242573 cites W2886477543 @default.
• W4297242573 cites W2898378268 @default.
• W4297242573 cites W2913584903 @default.
• W4297242573 cites W2914739834 @default.
• W4297242573 cites W2917655541 @default.
• W4297242573 cites W2924618784 @default.
• W4297242573 cites W2947157460 @default.
• W4297242573 cites W2957101013 @default.
• W4297242573 cites W2998848372 @default.
• W4297242573 cites W3009223368 @default.
• W4297242573 cites W3015141169 @default.
• W4297242573 cites W3128456160 @default.
• W4297242573 cites W3145628054 @default.
• W4297242573 cites W3156620873 @default.
• W4297242573 cites W3165576985 @default.
• W4297242573 cites W3185610732 @default.
• W4297242573 cites W4206666777 @default.
• W4297242573 cites W4297242573 @default.
• W4297242573 doi "https://doi.org/10.1002/ijc.34304" @default.
• W4297242573 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36161271" @default.
• W4297242573 hasPublicationYear "2022" @default.
• W4297242573 type Work @default.
• W4297242573 citedByCount "2" @default.
• W4297242573 countsByYear W42972425732022 @default.
• W4297242573 countsByYear W42972425732023 @default.
• W4297242573 crossrefType "journal-article" @default.
• W4297242573 hasAuthorship W4297242573A5001731251 @default.
• W4297242573 hasAuthorship W4297242573A5006619822 @default.
• W4297242573 hasAuthorship W4297242573A5006642161 @default.
• W4297242573 hasAuthorship W4297242573A5015719789 @default.
• W4297242573 hasAuthorship W4297242573A5023263355 @default.
• W4297242573 hasAuthorship W4297242573A5025060489 @default.
• W4297242573 hasAuthorship W4297242573A5032686530 @default.
• W4297242573 hasAuthorship W4297242573A5034753221 @default.
• W4297242573 hasAuthorship W4297242573A5035439475 @default.
• W4297242573 hasAuthorship W4297242573A5041410352 @default.
• W4297242573 hasAuthorship W4297242573A5041911544 @default.
• W4297242573 hasAuthorship W4297242573A5043665560 @default.
• W4297242573 hasAuthorship W4297242573A5049369439 @default.
• W4297242573 hasAuthorship W4297242573A5053668514 @default.
• W4297242573 hasAuthorship W4297242573A5056961294 @default.
• W4297242573 hasAuthorship W4297242573A5067379430 @default.
• W4297242573 hasAuthorship W4297242573A5068016669 @default.
• W4297242573 hasAuthorship W4297242573A5079006574 @default.
• W4297242573 hasAuthorship W4297242573A5083142899 @default.
• W4297242573 hasAuthorship W4297242573A5083715943 @default.
• W4297242573 hasAuthorship W4297242573A5084631227 @default.
• W4297242573 hasAuthorship W4297242573A5090608495 @default.
• W4297242573 hasBestOaLocation W42972425731 @default.
• W4297242573 hasConcept C104317684 @default.
• W4297242573 hasConcept C109825262 @default.
• W4297242573 hasConcept C121608353 @default.
• W4297242573 hasConcept C126322002 @default.

• next